Get the Stockscreener App
24.99
0.42%
-0.1059
After Hours:
24.9941
Xoma Corporation stock is currently priced at $24.99, with a 24-hour trading volume of 1,387.
It has seen a -0.42% decreased in the last 24 hours and a -0.00% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $25.10 pivot point. If it approaches the $25.08 support level, significant changes may occur.
Previous Close:
$25.10
Open:
$25.2
24h Volume:
1,387
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.10%
1M Performance:
-0.00%
6M Performance:
+14.22%
1Y Performance:
+7.27%
1D Range:
$24.99
$25.20
52W Range:
$20.43
$25.85
Xoma Corporation Stock (XOMAO) Company Profile
Name
Xoma Corporation
Sector
Industry
Phone
510 204 7200
Address
2200 Powell Street, Suite 310, EmeryVille
Xoma Corporation Stock (XOMAO) Latest News
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
GlobeNewswire Inc.
XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
GlobeNewswire Inc.
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
GlobeNewswire Inc.
XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
GlobeNewswire Inc.
XOMA to Present at Upcoming Investor Conferences in March
GlobeNewswire Inc.
XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right
GlobeNewswire Inc.
Xoma Corporation Stock (XOMAO) Financials Data
There is no financial data for Xoma Corporation (XOMAO). Check out other stocks for more information.
About Xoma Corporation
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
1.62%
0.15%
Cap:
|
Volume (24h):